Total planned funding: $95,679,405
Allocations
Countries/Regions
Ukraine | $95,679,405 |
Organizational Types
Unknown | $28,418,021 |
Private Contractor | $19,293,782 |
NGO | $13,232,356 |
Multi-lateral Agency | $11,839,021 |
Own Agency | $9,253,819 |
Other USG Agency | $5,265,406 |
University | $5,127,000 |
Implementing Agency | $3,000,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $44,010,993 |
Prevention | $14,647,449 |
Treatment | $12,956,266 |
Care | $9,323,889 |
Testing | $8,724,749 |
Management and Operations | $6,016,059 |
Budget Codes
OHSS: Health Systems Strengthening | $20,857,946 |
HVSI: Strategic Information | $13,676,341 |
HTXS: Treatment: Adult Treatment | $10,325,152 |
HLAB: Laboratory Infrastructure | $9,476,706 |
HVCT: Testing: HIV Testing and Counseling | $8,724,749 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,136,936 |
HVMS: Management and Operations | $6,016,059 |
HVTB: Care: TB/HIV | $5,606,596 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,254,144 |
HTXD: Treatment: ARV Drugs | $2,631,114 |
HMBL: Biomedical Prevention: Blood Safety | $2,566,118 |
HKID: Care: Orphans and Vulnerable Children | $1,859,634 |
HBHC: Care: Adult Care and Support | $1,857,659 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $146,894 |
Top Partner Programs
Not Available:
$28,418,021
Countries/Regions
Deloitte Consulting Limited:
$10,625,011
Countries/Regions
USG Aggregated Agencies:
$8,438,819
Countries/Regions
Chemonics International:
$7,168,771
Countries/Regions